The Webcam system: A simple, automated, computer-based video system for quantitative measurement of movement in nonhuman primates

Journal of Neuroscience Methods

Volumn 145, Issue 1-2, 2005, Pages 159-166

  Togasaki, Daniel M ^a   Hsu, Albert ^a   Samant, Meghana ^a   Farzan, Bijan ^a   DeLanney, Louis E ^a   Langston, J William ^a   Di Monte, Donato A ^a   Quik, Maryka ^a  

^a PARKINSON S INSTITUTE   (United States)

Author keywords

Animal; Monkey; Motor activity; Movement analysis; Parkinson; Video

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MOVEMENT; COMPUTER ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; COMPUTER GRAPHICS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; IMAGE ANALYSIS; INFRARED RADIATION; LOCOMOTION; MICROCOMPUTER; MOTOR ACTIVITY; NONHUMAN; PARKINSONISM; PRIMATE; PRIORITY JOURNAL; TELEVISION CAMERA; VALIDATION PROCESS;

ANIMALS; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; MOTOR ACTIVITY; PARKINSONIAN DISORDERS; REPRODUCIBILITY OF RESULTS; SAIMIRI; SENSITIVITY AND SPECIFICITY; VIDEO RECORDING;

EID: 19544363603     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2004.12.010     Document Type: Article

References (21)

1. C. Barcia, V. De Pablos, V. Bautista-Hernandez, A. Sanchez-Bahillo, A. Fernandez-Barreiro, and M. Poza Measurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity J Neurosci Methods 134 2004 59 64
2. A. Benazzouz, T. Boraud, P. Dubedat, A. Boireau, J.M. Stutzmann, and C. Gross Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study Eur J Pharmacol 284 1995 299 307
3. P.J. Blanchet, S. Konitsiotis, and T.N. Chase Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys J Pharmacol Exp Ther 283 1997 794 799
4. C. Chassain, A. Eschalier, and F. Durif Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP J Neurosci Methods 111 2001 9 16
5. M.E. Emborg, S.Y. Ma, E.J. Mufson, A.I. Levey, M.D. Taylor, and W.D. Brown Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys J Comp Neurol 401 1998 253 265
6. B. Gomez-Mancilla, and P.J. Bedard Effect of nondopaminergic drugs on l-dopa-induced dyskinesias in MPTP-treated monkeys Clin Neuropharmacol 16 1993 418 427
7. T. Hashimoto, Y. Izawa, H. Yokoyama, T. Kato, and T. Moriizumi A new video/computer method to measure the amount of overall movement in experimental animals (two-dimensional object-difference method) J Neurosci Methods 91 1999 115 122
8. O. Hornykiewicz Biochemical aspects of Parkinson's disease Neurology 51 1998 S2 S9
9. A. Hsu, D.M. Togasaki, E. Bezard, P. Sokoloff, J.W. Langston, and D.A. Di Monte Effect of the D3 dopamine receptor partial agonist BP897 on l-dopa-induced dyskinesias and parkinsonism in squirrel monkeys J Pharmacol Exp Ther 311 2004 770 777
10. I. Irwin, L.E. DeLanney, L.S. Forno, K.T. Finnegan, D.A. Di Monte, and J.W. Langston The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey. Brain Res 531 1990 242 252
11. R. Kurlan, M.H. Kim, and D.M. Gash Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey Parkinsonism Mov Disord 6 1991 111 118
12. J.W. Langston, L.S. Forno, C.S. Rebert, and I. Irwin Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 292 1984 390 394
13. J.W. Langston, M. Quik, G. Petzinger, M. Jakowec, and D.A. Di Monte Investigating levodopa-induced dyskinesias in the parkinsonian primate Ann Neurol 47 2000 S79 S89
14. S. Moussaoui, M.C. Obinu, N. Daniel, M. Reibaud, V. Blanchard, and A. Imperato The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease Exp Neurol 166 2000 235 245
15. S.M. Papa, and T.N. Chase Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys Ann Neurol 39 1996 574 578
16. R.K. Pearce, M. Jackson, L. Smith, P. Jenner, and C.D. Marsden Chronic l-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated common marmoset (Callithrix jacchus) Mov Disord 10 1995 731 740
17. B. Samuelson, M. Wangenheim, and H. Wos A device for three-dimensional registration of human movement Ergonomics 30 1987 1655 1670
18. G. Sandstrom, A. Backstrom, and K.A. Olsson REMAC: a video-based motion analyser interfacing to an existing flexible sampling system J Neurosci Methods 69 1996 205 211
19. J.S. Schneider, T.I. Lidsky, T. Hawks, J.C. Mazziotta, and J.M. Hoffman Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation, and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion Brain Res 672 1995 112 117
20. R.D. Smith, Z. Zhang, R. Kurlan, M. McDermott, and D.M. Gash Developing a stable bilateral model of parkinsonism in rhesus monkeys Neuroscience 52 1993 7 16
21. L.C. Tan, P.H. Protell, J.W. Langston, and D.M. Togasaki The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys Mov Disord 17 2002 902 909